Zhao C - Search Results

1

[¹⁸F]AlF-NOTA-FAPI-04 PET/CT uptake in metastatic lesions on PET/CT imaging might distinguish different pathological types of lung cancer.

Wei Y, Cheng K, Fu Z, Zheng J, Mu Z, Zhao C, Liu X, Wang S, Yu J, Yuan S. Wei Y, et al. Among authors: zhao c. Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1671-1681. doi: 10.1007/s00259-021-05638-z. Epub 2021 Dec 6. Eur J Nucl Med Mol Imaging. 2022. PMID: 34870727 Free PMC article.

2

Plasma Markers for Early Prediction of Radiation-Induced Myocardial Damage.

Tao Y, Li P, Zhao C, Mu Z, Li Y, Yuan S, Wei Y. Tao Y, et al. Among authors: zhao c. J Interferon Cytokine Res. 2023 Apr;43(4):173-181. doi: 10.1089/jir.2022.0226. J Interferon Cytokine Res. 2023. PMID: 37062819 Free PMC article.

3

Different distant metastasis patterns based on tumor size could be found in extensive-stage small cell lung cancer patients: a large, population-based SEER study.

Li J, Liu F, Yu H, Zhao C, Li Z, Wang H. Li J, et al. Among authors: zhao c. PeerJ. 2019 Dec 3;7:e8163. doi: 10.7717/peerj.8163. eCollection 2019. PeerJ. 2019. PMID: 31824772 Free PMC article.

4

Survival analysis for non-squamous NSCLC patients harbored STK11 or KEAP1 mutation receiving atezolizumab.

Shang X, Li Z, Sun J, Zhao C, Lin J, Wang H. Shang X, et al. Among authors: zhao c. Lung Cancer. 2021 Apr;154:105-112. doi: 10.1016/j.lungcan.2021.02.010. Epub 2021 Feb 17. Lung Cancer. 2021. PMID: 33640623

5

Genetic alternations and immune characteristics in patients with small cell lung cancer.

Zhang C, Zhao C, Wang H. Zhang C, et al. Among authors: zhao c. Cancer Commun (Lond). 2021 Oct;41(10):1075-1078. doi: 10.1002/cac2.12208. Epub 2021 Aug 24. Cancer Commun (Lond). 2021. PMID: 34427988 Free PMC article. No abstract available.

6

Construction of a Diagnostic Model for Small Cell Lung Cancer Combining Metabolomics and Integrated Machine Learning.

Shang X, Zhang C, Kong R, Zhao C, Wang H. Shang X, et al. Among authors: zhao c. Oncologist. 2024 Mar 4;29(3):e392-e401. doi: 10.1093/oncolo/oyad261. Oncologist. 2024. PMID: 37706531 Free PMC article.

7

Comprehensive analysis of multiple parameters associated with tumor immune microenvironment in ARID1A mutant cancers.

Li Z, Lin J, Zhang L, Li J, Zhang Y, Zhao C, Wang H. Li Z, et al. Among authors: zhao c. Future Oncol. 2020 Oct;16(29):2295-2306. doi: 10.2217/fon-2020-0243. Epub 2020 Jul 8. Future Oncol. 2020. PMID: 32639175

8

PDL1 high expression without TP53, KEAP1 and EPHA5 mutations could better predict survival for patients with NSCLC receiving atezolizumab.

Wang H, Shan Q, Guo J, Han X, Zhao C, Li H, Wang Z. Wang H, et al. Among authors: zhao c. Lung Cancer. 2021 Jan;151:76-83. doi: 10.1016/j.lungcan.2020.11.006. Epub 2020 Nov 13. Lung Cancer. 2021. PMID: 33246647

9

Incorporating the Number of PLN into the AJCC Stage Could Better Predict the Survival for Patients with NSCLC: A Large Population-Based Study.

Shang X, Li Z, Lin J, Yu H, Zhao C, Wang H, Sun J. Shang X, et al. Among authors: zhao c. J Oncol. 2020 Dec 11;2020:1087237. doi: 10.1155/2020/1087237. eCollection 2020. J Oncol. 2020. PMID: 33381175 Free PMC article.

10

A 5-Genomic Mutation Signature Can Predict the Survival for Patients With NSCLC Receiving Atezolizumab.

Lin J, Wang X, Zhang C, Bu S, Zhao C, Wang H. Lin J, et al. Among authors: zhao c. Front Immunol. 2021 Jun 23;12:606027. doi: 10.3389/fimmu.2021.606027. eCollection 2021. Front Immunol. 2021. PMID: 34248926 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,322 results

Search Page

Filters